CytomX Therapeutics (6C1.F) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.18
-0.04
0.1
0.24

Details

Expected EPS
-0.053898493439999993
Actual EPS
0
Surprise EPS
0.05
Surprise Percent
+100%

Description

CytomX Therapeutics (6C1.F) will report earnings of for Q3 2025 on August 07, 2025.

0 Comments

Share your thoughts